Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 30 clinical trials
HIV Pre-exposure Prophylaxis Implementation Study in South Korea

The primary objective of this study is to examine acceptability, patterns of use, rates of adherence, safety , and measured levels of drug when high risk men who have sex with men (MSM) are provided open-label tenofovir/emtricitabine (TDF/FTC) for PrEP in South Korea. Secondary objectives are 1) to evaluate HIV …

emtricitabine
immune globulin
HIV Vaccine
tenofovir
pre-exposure prophylaxis (prep)
  • 0 views
  • 26 Jan, 2021
Registry of Management Strategies for Patients With COVID-19 in Healthcare Establishments

The purpose of the study is to describe medical care strategies implemented by healthcare establishments for patients affected by COVID-19

  • 0 views
  • 03 Nov, 2021
  • 1 location
Tolerability of Lopinavir Versus Dolutegravir for Children and Adolescents Living With HIV (LoDoCA)

Dolutegravir-based antiretroviral therapy is set to be increasingly replace ritonavir-boosted lopinavir-based regimens for the treatment of paediatric HIV. This prospective cohort study aims to

  • 0 views
  • 10 Aug, 2022
  • 1 location
Non-Interventional Observational Retrospective Study to Evaluate Doravirine Based-regimens in HIV Infected Aged Patients (DORAge). (DORAge)

The HIV-infected population is aging due to the success of combination antiretroviral therapy, which prolongs survival, as well as the growing number of newly diagnosed cases in adults 50 years old and over. This real-life, observational and retrospective study aims to evaluate the virological efficacy, toxicity and tolerability of Doravirine-based …

Accepts healthy volunteers
  • 0 views
  • 24 Mar, 2022
Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 (CovidTox)

used molecules, including but not limited to protease inhibitors (lopinavir/ritonavir), chloroquine, azithromycin, remdesivir and interferon beta-1a. Analyses of reports also include the International

lopinavir
covid-19
remdesivir
coronavirus
azithromycin
  • 10 views
  • 02 Mar, 2022
  • 1 location
TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2 (TURN-COVID)

given within 3 to 7 days after state of symptoms. Moreover, novel oral anti-viral compunds such as molnupiravir and nirmatrelvir/ritonavir could reduce the risk of hospitalisation or death by 30% to89

  • 0 views
  • 21 Mar, 2022
  • 5 locations
Simplified Treatment of Anti-retrovirus in China (C-STAR)

To observe the efficacy and safety of simplified therapy regimen for treating with HIV-1 infected patients in Chinese real word.

  • 1 views
  • 05 Mar, 2022
  • 1 location
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women. (APR)

The purpose of the Antiretroviral Pregnancy Registry (Registry) is to detect any major teratogenic effect involving any of the Registry drugs when administered to pregnant women. Registration is voluntary and confidential with information obtained from the health care provider. A Registry-assigned identifier allows for follow-up capability. Information on subjects is …

antiretroviral agents
antiretrovirals
prenatal
antiretroviral
hepatitis
  • 70 views
  • 04 May, 2022
  • 1 location
Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study

between specific treatments, including but not limited to vaccines targeted against SARS-CoV-2, hydroxychloroquine, azithromycin, remdesivir, baricitinib, tocilizumab, sarilumab, lopinavir/ritonavir and

assisted ventilation
assisted breathing
oseltamivir
remdesivir
baricitinib
  • 67 views
  • 05 Mar, 2022
  • 2 locations
Bictegravir in the Elderly Living With HIV (BICEP)

This is a prospective, open-label, single center, post-approval and post-marketing study. Current national guideline recommends an integrase strand inhibitors (INSTI) in combination with two nucleoside reverse transcriptase inhibitors (NRTIs) as standard of therapy for HIV-1 infected patients. INSTI-based regimen may require a potent CYP3A inhibitor such as cobicistat to increase …

  • 0 views
  • 06 Oct, 2021
  • 1 location